Skip to main content
OpenTrials
Completed

NCT Number: NCT05390398

Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention

The SoFiT study is a randomized controlled trial examining the effects of a behaviour change guided lifestyle intervention on increasing adherence to the World Cancer Research Fund cancer prevention guidelines, compared to the wait-list usual care group, on diminishing cancer-related fatigue in colorectal cancer survivors.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Wageningen University & Research

Wageningen, Gelderland, 6708WE, Netherlands

About this study

The SoFiT study is a randomized controlled trial examining the effects of a behaviour change guided lifestyle intervention on increasing adherence to the World Cancer Research Fund (WCRF) cancer prevention guidelines, compared to the wait-list usual care group, on diminishing cancer-related fatigue in colorectal cancer survivors.

Colorectal cancer survivors who completed treatment six months to five years ago and who suffer from cancer-related fatigue, are randomized into two parallel groups: an intervention group or the wait-list usual care group. The intervention group follows a six-month personalized lifestyle program, which is guided by behaviour change techniques, to increase adherence to the World Cancer Research Fund cancer prevention guidelines on healthy nutrition, physical activity and healthy weight. Participants are guided by a lifestyle coach specialized in behaviour change. The wait-list usual care group receives a lifestyle program after the intervention period of six months: this includes two personalized behavioural coaching sessions and any material that the intervention group also received.

Both groups participate in measurements at baseline, three months, at the end of the intervention (six months) and at follow-up (twelve months). The follow-up timepoint is included to study long-term behavioural lifestyle change. The primary outcome is the change in cancer-related fatigue, as measured by the FACIT-Fatigue questionnaire, between the intervention and wait-list usual care group from baseline till six months.

Secondary outcomes include cancer-related fatigue (at other timepoints), skeletal muscle fat infiltration and cross-sectional area, gut microbiota composition, health-related quality of life, physical performance, sleep quality and duration, depression and anxiety, behavioural determinants and adherence to the WCRF guidelines by assessing habitual dietary intake, physical activity level, height, weight, waist circumference and BMI. Other outcomes of interest include, blood pressure, chrono-nutrition, colorectal cancer related complaints, hemoglobin blood levels, self-reported weight (at three months) and cost-effectiveness evaluation. Moreover, the following data will be collected to characterize the population: sociodemographic information (age, sex, marital status, education, smoking) and clinical parameters (time since diagnosis, current and received treatment, comorbidities, medicine and supplement use).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18 or above.
  • Completed curative stage I-III colorectal cancer treatment in the previous 6 months to 5 years.
  • Live on a reasonable distance from the research center at the Wageningen University & Research (WUR) (i.e. maximum of ± 1 hour away).
  • Classified as suffering from CRF through the Functional Assessment of Chronic Illness Therapy (FACIT) - Fatigue Scale questionnaire with cut-off score below 34 indicating fatigue.
  • Willingness to be randomized into either the intervention or wait-list control group.
  • Willing and able to follow the lifestyle intervention.
  • Able to understand and provide informed consent in Dutch.

Exclusion criteria

  • Planning to participate or participating in another medical research that could possibly interfere with the study results.
  • Excessive alcohol consumption (i.e. more than 4 glasses per day).
  • Chronic drug use and unwillingly to stop using drugs.
  • Unable/unwilling to comply with the intervention (e.g. through dementia, Alzheimer or mental illness)

Treatment and study plan

Behaviour change guided lifestyle intervention

Behavioral

Participants in the intervention group receive personalized coaching from a lifestyle coach on adhering to the World Cancer Research Fund cancer prevention guidelines. The lifestyle coach is specialized in behaviour change techniques and uses these as the core of the lifestyle coaching. For each participant behavioural determinants will be assessed and targeted with specific applicable behaviour change techniques.

Primary outcomes

  1. Change in cancer-related fatigue

    Time frame: Baseline till six months

    Cancer-related fatigue is assessed with the FACIT-Fatigue Scale, a 13 item questionnaire with scores ranging from 0-52. A score below 34 indicates fatigue. The minimal clinically important difference is reported to be 3.0 for this scale.

Secondary outcomes

  1. Cancer-related fatigue

    Time frame: Twelve months

    Cancer-related fatigue is assessed with the FACIT-Fatigue Scale, a 13 item questionnaire with scores ranging from 0-52. A score below 34 indicates fatigue. The minimal clinically important difference is reported to be 3.0 for this scale.

  2. Skeletal muscle fat infiltration and muscle circumference

    Time frame: Baseline and six months

    Echo intensity of the skeletal muscle rectus femoris, lateral gastrocnemius and biceps brachialis is measured using a portable ultrasound machine.

  3. Gut microbiota composition

    Time frame: Baseline and six months

    Faecal samples are collected and the microbiota composition in this will be analyzed. The investigators will use 16S rRNA sequencing data for the taxonomic characterization of the gut microbiota. Eventually shotgun sequencing may also be done.

  4. Health-related quality of life

    Time frame: Baseline and six months

    Health-related quality of life is measured with the Functional Assessment of Cancer Therapy - General (FACT-G) questionnaire, which contains the following domains of well-being: physical, social/family, emotional and functional. The 27-item questionnaire has scores ranging from 0 to 108.

  5. Physical performance (3-minute step test)

    Time frame: Baseline and six months

    This test indicates cardiovascular fitness by heart rate measurement for one minute after the completion of three minutes of stepping.

  6. Physical performance (5 times sit-to-stand test)

    Time frame: Baseline and six months

    This test indicates lower extremity skeletal muscle strength. The time necessary to achieve the standing position on the 5th repetition is measured.

  7. Physical performance (tandem test)

    Time frame: Baseline and six months

    This test measures balance for three different standing positions. Each position has to be maintained for 10 seconds in order to pass the test.

  8. Physical performance (chair sit-and-reach test)

    Time frame: Baseline and six months

    This test measures lower extremity and lower back flexibility. Participants sit on a chair and bend forward and reach for their toes. The distance between the hand and toes is measured.

  9. Physical performance (strength: hand dynamometer)

    Time frame: Baseline and six months

    This test uses a hand dynamometer to measure strength.

  10. Sleep quality and duration (Pittsburgh Sleep Quality Index)

    Time frame: Baseline, six months and 12 months

    Sleep quality is measured with the Pittsburgh Sleep Quality Index (PSQI), a 19-item questionnaire with scores ranging from 0-21. A score above 5 indicates bad sleep quality.

  11. Sleep quality and duration (Consensus sleep diary morning)

    Time frame: Baseline and six months

    The Consensus sleep diary morning (CSD), a 15-item diary, is used for measuring other sleep outcomes such as sleep onset latency and sleep duration.

  12. Depression

    Time frame: Baseline and six months

    Depression is measured using the 8-item Patient Healthcare Questionnaire (PHQ-8). It contains 8 items, and scores range from 0-24, with higher scores indicating a higher chance of depression.

  13. Anxiety

    Time frame: Baseline and six months

    Anxiety is measured using the 7-item Generalized Anxiety Disorder (GAD-7). The GAD-7 contains 7 items, its scores range from 0-21, with higher scores indicating a higher chance of anxiety.

  14. Behavioural determinants

    Time frame: Baseline, three months, six months and twelve months.

    Identified behavioural determinants through focus groups and a systematic review, are assessed using a self-reported questionnaire with questions based on previous reported questions on different determinants. These were adapted to reflect the WCRF guidelines. Higher scores for each of the determinants (scale 1-7) indicate better results.

  15. Habitual dietary intake (Food Frequency Questionnaire)

    Time frame: Baseline, six months and twelve months

    Nutritional intake is measured using a semi-quantitative Food Frequency Questionnaire (FFQ). Scores are calculated using the Dutch National Food Consumption tables. In addition, the validated questionnaire Eetscore is used, which contains a short online questionnaire (10-15 minutes) that serves as an indicator to assess diet quality, based on the Dutch Healthy Diet index 2015 (DHD15-index). Scores range from 0-160, with higher scores indicating better diet quality.

  16. Habitual dietary intake (Eetscore)

    Time frame: Baseline, three months, six months and twelve months

    Nutritional intake is also measured using the validated questionnaire Eetscore, which uses a short online questionnaire (10-15 minutes) that serves as an indicator to assess diet quality, based on the Dutch Healthy Diet index 2015 (DHD15-index). Scores range from 0-160, with higher scores indicating better diet quality.

  17. Physical activity level (Short QUestionnaire to ASsess Health-enhancing physical activity)

    Time frame: Baseline, three months, six months and twelve months

    Physical activity is measured using the Short QUestionnaire to ASsess Health-enhancing physical activity (SQUASH). The questions in the SQUASH are pre-structured in commuting, leisure time, household and work/school activities. Scores will be assigned to the different reported activities base on intensities in MET and translated to minutes of physical activity.

  18. Physical activity level (Accelerometer)

    Time frame: Baseline and six months

    Physical activity is also measured using ActivPalTM Micro3, an accelerometer measuring sedentary behaviour and physical activity. The ActivPalTM is worn for 9 days.

  19. Anthropometric measurements (Height)

    Time frame: Baseline and six months

    Height (in cm) is measured with a stadiometer.

  20. Anthropometric measurements (Weight)

    Time frame: Baseline, three months (self-reported) and six months

    Weight (in kg) is measured with a calibrated scale.

  21. Anthropometric measurements (Waist circumference)

    Time frame: Baseline and six months

    Waist circumference (in cm) is measured using tape measures.

  22. Cost-effectiveness evaluation

    Time frame: Baseline, three months and six months

    The cost-effectiveness of the intervention is evaluated using a questionnaire that includes items on for example costs that the participant has made in order to follow the lifestyle program.

Other outcomes

  1. Blood pressure

    Time frame: Baseline and six months

    Blood pressure is measured using a sphygmomanometer. Both diastolic and systolic blood pressure are measured.

  2. Heart rate

    Time frame: Baseline and six months

    Heart rate is measured using a sphygmomanometer.

  3. Chrono-nutrition

    Time frame: Baseline and six months

    Chrono-nutrition, the timing of dietary intake, is measured with the "Chromes vragenlijst patiënten eetpatronen". This is a Dutch questionnaire containing 26 items that assess meal regularity (8-items), meal frequency (7-items), and meal clock time (11-items).

  4. Colorectal cancer related complaints

    Time frame: Baseline and six months

    Measuring colorectal cancer specific problems is done using the additional concerns (i.e. subscale) of the Functional Assessment of Cancer Therapy - Colorectal (FACT-C). This questionnaire contains 9 items and scores are ranging from 0-28 points.

  5. Hemoglobin levels

    Time frame: Baseline and six months

    Finger prick blood sampling is used for assessing haemoglobin status as an indicator for anaemia.

  6. Sociodemographic information

    Time frame: Baseline (and six months)

    Sociodemographic information is collected using standardized questionnaires.

  7. Clinical parameters

    Time frame: Baseline (and six months)

    Clinical parameters such as time since diagnosis, current and received treatment, comorbidities and medicine use, are collected either via standardized questionnaires or from medical records (part of informed consent).

Sponsors and collaborators

Lead sponsor

Wageningen University

Other

Collaborators

  • Deventer Ziekenhuis
  • Flevoziekenhuis
  • Gelderse Vallei Hospital
  • Het Prospectief Landelijk CRC cohort (PLCRC)
  • Rijnstate Hospital
  • Slingeland Hospital
  • World Cancer Research Fund International

Registry information

Acronym: SoFiT

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
May 25, 2022
Registry last updated
Mar 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.